Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Johanna M. Tuomela"'
Autor:
Tamiko Ishizu, Dominik Eichin, Artur Padzik, Sanni Tuominen, Reidar Grénman, Marko Salmi, Tove J. Grönroos, Johanna M. Tuomela
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-13 (2021)
Abstract Background A low tissue oxygen level,
Externí odkaz:
https://doaj.org/article/cac31ac4ef344e469ea3e5f82f8ce4d3
Autor:
Tiina E. Kähkönen, Johanna M. Tuomela, Tove J. Grönroos, Jussi M. Halleen, Kaisa K. Ivaska, Pirkko L. Härkönen
Publikováno v:
Journal of Bone Oncology, Vol 16, Iss , Pp - (2019)
Advanced breast cancer has a high incidence of bone metastases. In bone, breast cancer cells induce osteolytic or mixed bone lesions by inducing an imbalance in bone formation and resorption. Activated fibroblast growth factor receptors (FGFRs) are i
Externí odkaz:
https://doaj.org/article/92fc1a7f28f245bea1627d5eca2a8af3
Autor:
Madison R Chandler, Kimberly S Keene, Johanna M Tuomela, Andres Forero-Torres, Renee Desmond, Katri S Vuopala, Kevin W Harris, Nancy D Merner, Katri S Selander
Publikováno v:
PLoS ONE, Vol 12, Iss 9, p e0183832 (2017)
Toll-like receptor 9 (TLR9) is an innate immune system DNA-receptor that regulates tumor invasion and immunity in vitro. Low tumor TLR9 expression has been associated with poor survival in Caucasian patients with triple negative breast cancer (TNBC).
Externí odkaz:
https://doaj.org/article/82fcacfe1fee4d6e887f5591379aac40
Autor:
Kati M Tarkkonen, Emeli M Nilsson, Tiina E Kähkönen, Julien H Dey, Jari E Heikkilä, Johanna M Tuomela, Qing Liu, Nancy E Hynes, Pirkko L Härkönen
Publikováno v:
PLoS ONE, Vol 7, Iss 11, p e49970 (2012)
Fibroblast growth factors (FGFs) regulate the growth and progression of breast cancer. FGF signaling is transduced through FGF receptors 1-4, which have oncogenic or anti-oncogenic roles depending on the ligand and the cellular context. Our aim was t
Externí odkaz:
https://doaj.org/article/f9b86713200448d0bd2888a412913140